Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis

M. Simon (Cluj-Napoca, Romania), A. Harangus (Cluj-Napoca, Romania), I. Simon (Cluj-Napoca, Romania), S. Popevic (Belgrade, Republic of Serbia), D. Jovanovic (Belgrade, Republic of Serbia)

Source: International Congress 2018 – Bronchoscopy and transthoracic ultrasound
Session: Bronchoscopy and transthoracic ultrasound
Session type: Thematic Poster
Number: 4180
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Simon (Cluj-Napoca, Romania), A. Harangus (Cluj-Napoca, Romania), I. Simon (Cluj-Napoca, Romania), S. Popevic (Belgrade, Republic of Serbia), D. Jovanovic (Belgrade, Republic of Serbia). Immunocytological study of bronchioloalveolar lavage (BAL) in interstitial lung diseases (ILD) diagnosis. 4180

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The impact of age on bronchoalveolar lavage (BAL) cytoimmunological pattern in interstitial lung diseases (ILD) and in healthy controls
Source: International Congress 2014 – ILDs 4
Year: 2014

Induced sputum (IS) in patients with interstitial lung disease (ILD) – comparison with bronchoalveolar lavage (BAL)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


The role of the combined assessment of the bronchoalveolar lavage (BAL) and radiological profile in the diagnosis of chronic eosinophilic pneumonia (CEP)
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013


Bronchoalveolar lavage fluid cell profile (BALF) as a predictor of the prognosis in Japanese patients with idiopathic pulmonary fibrosis/usual interstitial pneumonia (IPF/UIP)
Source: Eur Respir J 2004; 24: Suppl. 48, 46s
Year: 2004

Cytofluorimetric BAL cells characterization in IPF and in other ILD
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016

The clinical utility of bronchoalveolar lavage in diffuse parenchymal lung disease
Source: Eur Respir Rev 2010 19: 237-241
Year: 2010



Transbronchial lung cryobiopsy (TBLC) and bronchoalveolar lavage (BAL) in diagnosis of Intersticial Lung Diseases (ILD)
Source: International Congress 2019 – Interventional pulmonology techniques: targeting selective lung tissue
Year: 2019


The diagnostic value of bronchoalvolar lavage (BAL) in the diagnosis of peripheral lung cancer (PLC)
Source: Eur Respir J 2003; 22: Suppl. 45, 253s
Year: 2003

Bronchoalveolar lavage findings in patients with diffuse interstitial lung disease (DILDs)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Fibrocytes are detected in bronchoalveolar lavage (BAL) fluid in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Bronchoalveolar lavage: how can we use it more effectively to define pathology?
Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases
Year: 2006


A comparison of T lymphocytes (TLs) subpopulations in lung tissue and in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2004; 24: Suppl. 48, 43s
Year: 2004

The impact of age on broncholaveolar lavage (BAL) cytoimmunological results in nonsmoking patients with interstitial lung diseases (ILD) and in healthy volunteers
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008


Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Influence of systemic steroid treatment on bronchoalveolar (BAL) cytological composition and cell cycle in selected interstitial lung diseases
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Studies on hepatocyte growth factor (HGF) in bronchoalveolar lavage (BAL) do not support the concept on its antifibrotic properties in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015

Induced sputum versus bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2003; 22: Suppl. 45, 227s
Year: 2003